Clinical trial
Provigil (Modafinil) Study by Taiwan Biotech Co.
NCT00174174 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00174174 |
|---|---|
| Title | Provigil (Modafinil) Study by Taiwan Biotech Co. |
| Official title | A Placebo Control, Double Blind, Cross Over Study of Modafinil in Patients With Narcolepsy |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Narcolepsy, Cataplexy, Sleep Disorders, Hypersomnolence, Excessive Sleepiness |
| Intervention type | Drug |
| Interventions | Modafinil |
| Enrollment | 30 |
| Start date | Sep 1, 2003 |
| First posted | Sep 15, 2005 |
| Last update posted | Sep 15, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: